[1] Xiao ZF,Yang ZY,Wang LH,et al. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys,2005,62:82-90. [2] 何健,曾昭冲,王群,等.食管癌术后淋巴结转移术后局部小野放疗疗效.中国临床医学,2006,13:921-923. [3] 乔学英,周道安,蔺强,等.食管癌术后预防照射范围的临床研究.中华放射肿瘤学杂志,2006,15:379. [4] 肖泽芬,周宗玫,吕纪马,等.胸段食管癌淋巴结转移规律与术后放疗范围的探讨.中华放射肿瘤学杂志,2008,17:427. [5] Tachibana M,Kinugasa S,Yoshimura H,et al. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg,2005,189:98-109. [6] Lu JC,Tao H,Chen ZZ,et al. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery. Dis Esophagus,2009,22:490-495. [7] Tepper J,Krasna MJ,Niedzwiecki D. Phase Ⅲ trial of trimodality therapy with cisplatin,fluorouracil,radiotherapy,and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol,2008,26:1086-1092.
2012, Vol. 21 
